These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 24475257)
41. Serum levels of copper, zinc and disease severity scores in sickle cell disease patients in Benin City, Nigeria. Emokpae MA; Fatimehin EB; Obazelu PA Afr Health Sci; 2019 Sep; 19(3):2798-2805. PubMed ID: 32127853 [TBL] [Abstract][Full Text] [Related]
42. Extracellular microvesicle microRNAs in children with sickle cell anaemia with divergent clinical phenotypes. Khalyfa A; Khalyfa AA; Akbarpour M; Connes P; Romana M; Lapping-Carr G; Zhang C; Andrade J; Gozal D Br J Haematol; 2016 Sep; 174(5):786-98. PubMed ID: 27161653 [TBL] [Abstract][Full Text] [Related]
43. Are there phases to the vaso-occlusive painful episode in sickle cell disease? Jacob E; Beyer JE; Miaskowski C; Savedra M; Treadwell M; Styles L J Pain Symptom Manage; 2005 Apr; 29(4):392-400. PubMed ID: 15857743 [TBL] [Abstract][Full Text] [Related]
44. Cell-derived microparticles and sickle cell disease chronic vasculopathy in sub-Saharan Africa: A multinational study. Dembélé AK; Lapoumeroulie C; Diaw M; Tessougue O; Offredo L; Diallo DA; Diop S; Elion J; Colin-Aronovicz Y; Tharaux PL; Jouven X; Romana M; Ranque B; Le Van Kim C Br J Haematol; 2021 Feb; 192(3):634-642. PubMed ID: 33249569 [TBL] [Abstract][Full Text] [Related]
45. Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patients. Olatunya OS; Lanaro C; Longhini AL; Penteado CFF; Fertrin KY; Adekile A; Saad STO; Costa FF Ann Hematol; 2019 Nov; 98(11):2507-2521. PubMed ID: 31493004 [TBL] [Abstract][Full Text] [Related]
46. Relevance of fibrinolytic protein (D-dimer) and fibrinopeptide A as markers of sickle cell anaemia vaso-occlusive crisis. Ekwere TA; Ebele U; Ekanem M; Ogunro PS Niger Postgrad Med J; 2014 Sep; 21(3):225-30. PubMed ID: 25331238 [TBL] [Abstract][Full Text] [Related]
47. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus. Burbano C; Villar-Vesga J; Orejuela J; Muñoz C; Vanegas A; Vásquez G; Rojas M; Castaño D Front Immunol; 2018; 9():322. PubMed ID: 29545790 [TBL] [Abstract][Full Text] [Related]
48. Microparticles as biomarkers of osteonecrosis of the hip in sickle cell disease. Marsh A; Schiffelers R; Kuypers F; Larkin S; Gildengorin G; van Solinge W; Hoppe C Br J Haematol; 2015 Jan; 168(1):135-8. PubMed ID: 25196812 [TBL] [Abstract][Full Text] [Related]
49. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Brittain HA; Eckman JR; Swerlick RA; Howard RJ; Wick TM Blood; 1993 Apr; 81(8):2137-43. PubMed ID: 8471771 [TBL] [Abstract][Full Text] [Related]
50. Impact of splenectomy on circulating microparticles in patients with sickle cell anemia. Boulassel MR; Al-Rubkhi K; Al-Qasabi J; El-Ghamry I; Khan H; Panjwani V; Qureshi RN; Al-Mamari S; Al-Qarni Z; Al-Kindi M; Al-Nabhani A; Al-Gharibi K; Wali Y; Pathare A Int J Lab Hematol; 2024 Feb; 46(1):141-147. PubMed ID: 37661331 [TBL] [Abstract][Full Text] [Related]